Mark Barakat

1.5k total citations · 1 hit paper
41 papers, 786 citations indexed

About

Mark Barakat is a scholar working on Ophthalmology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Barakat has authored 41 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Ophthalmology, 12 papers in Surgery and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Barakat's work include Retinal Diseases and Treatments (22 papers), Retinal and Optic Conditions (13 papers) and Retinal Imaging and Analysis (8 papers). Mark Barakat is often cited by papers focused on Retinal Diseases and Treatments (22 papers), Retinal and Optic Conditions (13 papers) and Retinal Imaging and Analysis (8 papers). Mark Barakat collaborates with scholars based in United States, Switzerland and Germany. Mark Barakat's co-authors include Charles C. Wykoff, Peter K. Kaiser, Ann H. Milam, Linda Rose, Artur V. Cideciyan, Val C. Sheffield, Tomás S. Alemán, Nisha Gupta, Edwin M. Stone and Samuel G. Jacobson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mark Barakat

38 papers receiving 755 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

2023 90 citations Arshad M. Khanani, Ashwin Gupta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Barakat United States	14	467	341	224	77	51	41	786
Shahram Samiei Iran	13	102 0.2×	240 0.7×	126 0.6×	32 0.4×	37 0.7×	45	432
Dorota Rogińska Poland	15	119 0.3×	287 0.8×	64 0.3×	75 1.0×	27 0.5×	48	620
Yuzuru Sasamoto United States	12	185 0.4×	236 0.7×	406 1.8×	15 0.2×	47 0.9×	26	722
James Wong Australia	9	295 0.6×	49 0.1×	270 1.2×	19 0.2×	25 0.5×	17	461
Tai‐Chi Lin Taiwan	14	262 0.6×	262 0.8×	171 0.8×	78 1.0×	60 1.2×	62	628
Claude Giasson Canada	19	300 0.6×	202 0.6×	717 3.2×	28 0.4×	90 1.8×	39	1.1k
Andrew S. Gurwood United States	9	170 0.4×	177 0.5×	85 0.4×	77 1.0×	31 0.6×	40	468
Zhizhong Ma China	19	784 1.7×	494 1.4×	454 2.0×	65 0.8×	134 2.6×	86	1.2k
Mohammad Riazi-Esfahani Iran	17	381 0.8×	124 0.4×	428 1.9×	23 0.3×	16 0.3×	38	670
Mei Hong Tan United Kingdom	12	275 0.6×	251 0.7×	212 0.9×	74 1.0×	38 0.7×	19	587

Countries citing papers authored by Mark Barakat

Since Specialization

Citations

This map shows the geographic impact of Mark Barakat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Barakat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Barakat more than expected).

Fields of papers citing papers by Mark Barakat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Barakat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Barakat. The network helps show where Mark Barakat may publish in the future.

Co-authorship network of co-authors of Mark Barakat

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Barakat. A scholar is included among the top collaborators of Mark Barakat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Barakat. Mark Barakat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barakat, Mark, et al.. (2025). Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe. Clinical ophthalmology. Volume 19. 395–406.

Zhou, Wenting, et al.. (2025). Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor. American Journal of Ophthalmology Case Reports. 38. 102308–102308. 1 indexed citations

Singh, Rishi P., Robert L. Avery, Mark Barakat, Judy E. Kim, & Szilárd Kiss. (2024). Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration. Ophthalmic surgery, lasers & imaging retina. 55(3). 156–162. 1 indexed citations

Barakat, Mark, David M. Brown, Rahul N. Khurana, et al.. (2024). Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial. SHILAP Revista de lepidopterología. 5(1). 100586–100586. 4 indexed citations

Li, Xu, Raúl Vélez-Montoya, Mark Barakat, et al.. (2024). Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease. Ophthalmology Science. 4(4). 100467–100467. 1 indexed citations

Patel, Sunil, Philip Storey, Mark Barakat, et al.. (2024). Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmology Science. 4(5). 100527–100527. 6 indexed citations

Barakat, Mark, et al.. (2024). Quality of Life after Treatment for Pelvic Organ Prolapse in Real-World Study: Recommendations, Vaginal Pessary, and Surgery. Medicina. 60(4). 547–547.

Wykoff, Charles C., Hidetaka Matsumoto, Mark Barakat, et al.. (2023). RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 43(7). 1051–1063. 21 indexed citations

Cornelissen, Anne, Matthew Kutyna, Qi Cheng, et al.. (2021). Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity. Cardiovascular revascularization medicine. 35. 129–138. 7 indexed citations

10.

Khurana, Rahul N., Pauline T. Merrill, Steven Yeh, et al.. (2021). Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). British Journal of Ophthalmology. 106(8). bjophthalmol–2020. 34 indexed citations

11.

Ciulla, Thomas A., Barry Kapik, Mark Barakat, et al.. (2021). Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema. American Journal of Ophthalmology. 237. 310–324. 10 indexed citations

12.

Barakat, Mark, et al.. (2020). Post hoc Analysis of Clinical Suprachoroidal Injection Experience across Indications. Investigative Ophthalmology & Visual Science. 61(7). 4954–4954. 3 indexed citations

13.

Barakat, Mark, Charles C. Wykoff, Víctor H. González, et al.. (2020). Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema. Ophthalmology Retina. 5(1). 60–70. 36 indexed citations

14.

Barakat, Mark, et al.. (2020). Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia. Cureus. 12(12). e11938–e11938. 3 indexed citations

15.

Abdallah, Walid, Mark Barakat, David Goldenberg, et al.. (2019). Assessing the Efficacy and Safety of Intravitreal Dexamethazone Implant in Treating Macular Edema in Eyes with an Incomplete Response to Anti-vascular Endothelial Growth Factor Agents.. Investigative Ophthalmology & Visual Science. 60(9). 98–98. 1 indexed citations

16.

Barakat, Mark, Neal Palejwala, Ashleigh L. Levison, et al.. (2017). No Clear Benefit of Vitrectomy for Post-Injection Endophthalmitis in Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 58(8). 5499–5499. 1 indexed citations

17.

Campochiaro, Peter A., Charles C. Wykoff, David M. Brown, et al.. (2017). Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study. Ophthalmology Retina. 2(4). 320–328. 69 indexed citations

18.

Richter, Götz M., Boris Radeleff, Christian Stroszczynski, et al.. (2017). Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study. CardioVascular and Interventional Radiology. 41(4). 587–593. 38 indexed citations

19.

Barakat, Mark, T.I. Metelitsina, Joan DuPont, & Juan E. Grunwald. (2006). Effect of Niacin on Retinal Vascular Diameter in Patients with Age-Related Macular Degeneration. Current Eye Research. 31(7-8). 629–634. 10 indexed citations

20.

Barakat, Mark, et al.. (2004). Automated drusen quantitaion for clinical trials. Investigative Ophthalmology & Visual Science. 45(13). 3017–3017. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact